![Richard Shea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Shea
Direttore/Membro del Consiglio presso
SYNLOGIC, INC.
Patrimonio netto: 10 544 $ in data 31/05/2026
Profilo
Richard P.
Shea is currently a Director at Synlogic Operating Co., Inc., an Independent Director at Synlogic, Inc. since 2017, and a Principle at Danforth Advisors LLC.
Formerly, Mr. Shea was Vice President-Finance at Genetics Institute LLC from 1992 to 1999, Chief Operating & Financial Officer at Variagenics, Inc. from 1999 to 2003, Chief Financial Officer & Senior Vice President at Momenta Pharmaceuticals, Inc. from 2015 to 2016, and CFO, Treasurer & Principal Accounting Officer at Syndax Pharmaceuticals, Inc. from 2017 to 2020.
Education includes an MBA from Boston University and an undergraduate degree from Princeton University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SYNLOGIC INC 0,13% | 31/03/2026 | 15.506 ( 0,13% ) | 10 544 $ | 31/05/2026 |
Posizioni attive di Richard Shea
| Società | Posizione | Inizio |
|---|---|---|
| SYNLOGIC, INC. | Direttore/Membro del Consiglio | 28/08/2017 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | - |
Precedenti posizioni note di Richard Shea
| Società | Posizione | Fine |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 13/07/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/12/2016 |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics | Direttore Finanziario/CFO | 01/04/2003 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore Finanziario/CFO | 01/01/1999 |
Formazione di Richard Shea
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Variagenics, Inc.
Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics | Commercial Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
